Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-02-12

EMA Authorised: Palforzia (defatted powder of Arachis hypogaea L., semen (peanuts)) — Stallergenes

View source ↗

Summary

The European Medicines Agency authorised Palforzia for peanut hypersensitivity in the EU. The product is a peanut allergen immunotherapy developed by Stallergen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palforzia (defatted powder of Arachis hypogaea L., semen (peanuts))

Snippet

Status: Authorised. Therapeutic area: Peanut Hypersensitivity. MAH: Stallergenes. Decision date: 05/12/2025